"Celebrated as a bipartisan victory, the omnibus bill Congress approved Thursday is yet another example of lawmakers' propensity for overspending. The massive $1.1 trillion spending package funnels more money that it should to defense and other domestic projects. Following the outline set by the Ryan-Murray plan, the bill spends above the levels set by the 2011 sequester and wastes loads of money on special interests."The big winners of this bipartisan spending orgy are the Pentagon and the military-industrial complex. Thanks to Congress' willingness to renege on its commitment to cut spending through sequestration, the Department of Defense won't be subjected to the cuts that had been planned for the next two years."A document prepared by the staff of Sen. Tom Coburn, R-Okla., shows the omnibus bill is also stuffed with funding for weapons not even requested by the Pentagon, including $90 million for Abrams tank upgrades to maintain "critical industrial base capability", $1.2 billion to the Navy's request to fully fund a second Virginia-class submarine in fiscal year 2014 (the Navy had requested partial funding), and eight additional MQ-9 Reaper UAVs on top of the 12 the Air Force requested."The Coburn document also shows that the omnibus funds research not requested by the Pentagon, including $6 million for human, social and culture behavior modeling, $46.7 million for weapons technology, and $70 million for common kill vehicle technology."But it gets worse, since the military not only scores more spending through its regular budget, but as a bonus it gets a raise through its Overseas Contingency Operations budget (the OCO or "war" budget)."Indeed, although the troop levels have gone down from 60,000 to 30,000 over the past year, the omnibus bill provides more spending for the war effort – $85.2 billion. That's an almost $5 billion hike over what the spendthrift Pentagon asked for..."
"The bill, for instance, includes $4 million for alcohol and substance abuse research, $12 million for Alzheimer's research, $120 million for breast cancer research, $10.5 million for lung cancer research, $20 million for ovarian cancer research, $80 million for prostate cancer research, and more – all of which are nondefense activities and overlap research performed by the National Institute of Health."